Now Available for Public Comment: Notice of Proposed Rulemaking (NPRM) for FDAAA 801 and NIH Draft Reporting Policy for NIH-Funded Trials

Assisted Nerve Blocks

This study has been completed.
Sponsor:
Information provided by (Responsible Party):
Thomas Hemmerling, McGill University Health Center
ClinicalTrials.gov Identifier:
NCT01436682
First received: September 19, 2011
Last updated: October 24, 2013
Last verified: October 2013
  Purpose

The study investigates assisted nerve blocks using an ultrasound machine.


Condition
Surgery

Study Type: Observational
Study Design: Observational Model: Case Control
Time Perspective: Prospective

Further study details as provided by McGill University Health Center:

Primary Outcome Measures:
  • Feasability of assisted nerve blocks [ Time Frame: 24h ] [ Designated as safety issue: No ]

Enrollment: 13
Study Start Date: September 2011
Study Completion Date: August 2013
Primary Completion Date: August 2013 (Final data collection date for primary outcome measure)
  Eligibility

Ages Eligible for Study:   18 Years to 90 Years
Genders Eligible for Study:   Both
Accepts Healthy Volunteers:   No
Sampling Method:   Non-Probability Sample
Study Population

Patient undergoing surgery which necessitates a peripheral nerve block to relieve postoperative pain.

Criteria

Inclusion Criteria:

  • indication for nerve blocks

Exclusion Criteria:

  • patient not able to provide the informed consent
  • allergy to local anesthetics
  Contacts and Locations
Choosing to participate in a study is an important personal decision. Talk with your doctor and family members or friends about deciding to join a study. To learn more about this study, you or your doctor may contact the study research staff using the Contacts provided below. For general information, see Learn About Clinical Studies.

Please refer to this study by its ClinicalTrials.gov identifier: NCT01436682

Locations
Canada, Quebec
Montreal General Hospital
Montreal, Quebec, Canada, H3G 1A4
Sponsors and Collaborators
McGill University Health Center
  More Information

No publications provided

Responsible Party: Thomas Hemmerling, Associate Professor, McGill University Health Center
ClinicalTrials.gov Identifier: NCT01436682     History of Changes
Other Study ID Numbers: GEN11-073
Study First Received: September 19, 2011
Last Updated: October 24, 2013
Health Authority: Canada: Ethics Review Committee

Keywords provided by McGill University Health Center:
Nerve Blocks

ClinicalTrials.gov processed this record on November 25, 2014